Dimenhydrinate

Revision as of 20:45, 22 January 2017 by Rossdonaldson1 (talk | contribs) (See Also)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Administration

Adult Dosing

  • 50mg PO/IV/IM q4-6h

Pediatric Dosing

  • 2-6yo: 12.5-25mg PO q6-8 hrs
  • 6-12yo: 25-50mg PO q6-8h
  • 1.25 mg/kg IM q6h

Special Populations

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

  • Nausea, vomiting
  • Sedation

Pharmacology

  • Half-life:
  • Metabolism: Liver
  • Excretion: Renal

Mechanism of Action

  • Precise anti-nausea mechanism unknown, has depressant action on hyperstimulated labyrinthine function

Comments

See Also

References